What Is FibroBiologics, Inc. (FBLG) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, FibroBiologics, Inc.'s intrinsic value is estimated at a composite fair value of $0.98. While the stock appears modestly undervalued at $0.84 (implied upside of +16.6%), our analysis suggests a thinner margin of safety across 4 of 6 bullish models. Notably, Dynamic NAV sees the most upside at +108.2% (fair value: $1.75), while Bayesian DCF is the most conservative at -83.4% ($0.14). The spread between these extremes — +191.6% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About FBLG?
6 of 13 models are currently active for FBLG. Of these, 4 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates FBLG's intrinsic value at $0.14, implying -83.4% downside from the current price. See which stocks rank higher →
How Does FBLG Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, FBLG ranks #290 by Quality of Company score. CirclFi's QOC score of 4.4/10 evaluates 32 fundamental signals. A score of 4.4 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
As a healthcare company, FibroBiologics, Inc. operates in a sector where patent cliff exposure is a critical driver of valuation. Investors evaluating FBLG should weigh these sector-specific dynamics alongside our model-derived fair values.
Is FBLG a Value Trap?
The Value Trap algorithm is not active for FBLG. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
6 of 13 models are active for FibroBiologics, Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, FibroBiologics, Inc.'s fundamental quality profile registers 4.4/10. This mixed score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +191.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every FBLG valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across FBLG's 6 active models, average confidence is 21%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad